Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ascorbic acid 1g effervescent tablets
0906031C0AAANAN
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 1g effervescent tablets sugar free
0906031C0AACCCC
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 200mg/5ml oral solution
0906031C0AABRBR
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 250mg tablets
0906031C0AAAPAP
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 250mg/5ml oral solution
0906031C0AAABAB
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 25mg/5ml oral solution
0906031C0AABFBF
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 500mg / Zinc citrate 5mg chew tab sugar free
091000000AABLBL
|
Generic compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Ascorbic acid 500mg / Zinc citrate 5mg modified-release caps
091000000AABQBQ
|
Generic compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Ascorbic acid 500mg chewable tablets sugar free
0906031C0AACBCB
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 500mg modified-release capsules
0906031C0AABABA
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 500mg/5ml solution for injection ampoules
0906031C0AAAAAA
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascorbic acid 50mg/5ml oral solution
0906031C0AABCBC
|
Ascorbic acid | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascur 100mg chewable tablets
0906031C0BZAABN
|
Ascur | Ascorbic acid | Nutrition and Blood | No data available |
|
Ascur 500mg chewable tablets
0906031C0BZABCB
|
Ascur | Ascorbic acid | Nutrition and Blood | No data available |
|
Asendis 100mg tablets
0403010C0BBACAC
|
Asendis | Amoxapine | Central Nervous System | No data available |
|
Asendis 50mg tablets
0403010C0BBABAB
|
Asendis | Amoxapine | Central Nervous System | No data available |
|
Asept 1000ml high vacuum drainage kit
21330000114
|
Asept 1000ml high vacuum drainage kit | Indwelling Pleural Cath Drain System | Appliances | No data available |
|
Asept 1000ml low vacuum drainage kit
21330000112
|
Asept 1000ml low vacuum drainage kit | Indwelling Pleural Cath Drain System | Appliances | No data available |
|
Asept 600ml high vacuum drainage kit
21330000113
|
Asept 600ml high vacuum drainage kit | Indwelling Pleural Cath Drain System | Appliances | No data available |
|
Asept 600ml low vacuum drainage kit
21330000111
|
Asept 600ml low vacuum drainage kit | Indwelling Pleural Cath Drain System | Appliances | No data available |
|
Aserbine cream
131107000BMAAAA
|
Proprietary compound preparation BNF 1311070 | Other desloughing agents | Skin | No data available |
|
Aserbine solution
131107000BMABAB
|
Proprietary compound preparation BNF 1311070 | Other desloughing agents | Skin | No data available |
|
Asfotase alfa 18mg/0.45ml solution for injection vials
0908010AMAAAAAA
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
|
Asfotase alfa 28mg/0.7ml solution for injection vials
0908010AMAAABAB
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
|
Asfotase alfa 40mg/1ml solution for injection vials
0908010AMAAACAC
|
Asfotase alfa | Asfotase alfa | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.